
{"id":4156,"date":"2025-05-21T07:00:34","date_gmt":"2025-05-21T07:00:34","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/"},"modified":"2026-01-22T14:04:29","modified_gmt":"2026-01-22T14:04:29","slug":"high-content-screen-nlrp1-inflammasome-modulators","status":"publish","type":"poster","link":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/","title":{"rendered":"A &lsquo;Speckulative&rsquo; Screen: High-Content MTS Against NLRP1 Mediated Inflammasome Formation"},"content":{"rendered":"<p><span style=\"font-size: 14pt;\">Sygnature Discovery presents a poster exploring the development of a robust high-content screening platform to uncover small molecule modulators of NLRP1-mediated inflammasome formation. This fixed-endpoint, image-based assay uses ASC::GFP-labelled cells to visualise inflammasome speck formation and assess the impact of 5,120 diverse compounds from Sygnature\u2019s LeadFinder library to identify potential modulators of NLRP1 mediated inflammasome formation as a key pattern recognition receptor.<\/span><\/p>\n<h2><span style=\"font-size: 14pt;\"><strong>Our NLRP1 Inflammasome Screening Highlights<\/strong><\/span><\/h2>\n<p>A fixed-endpoint assay was established to identify potential modulators of\u00a0 inflammasome formation.<\/p>\n<ul>\n<li data-start=\"489\" data-end=\"576\"><span style=\"font-size: 12pt;\">High-content imaging to track speck formation as a readout of inflammasome activation<\/span><\/li>\n<li data-start=\"579\" data-end=\"637\"><span style=\"font-size: 12pt;\">5120-compound primary screen yielding 70+ modulating hits<\/span><\/li>\n<li data-start=\"640\" data-end=\"709\"><span style=\"font-size: 12pt;\">Potency profiling revealed multiple novel activators and inhibitors<\/span><\/li>\n<\/ul>\n<h2 data-start=\"0\" data-end=\"61\"><span style=\"font-size: 14pt;\"><strong data-start=\"0\" data-end=\"61\">Advancing Innate Immunity Research Through HTS Innovation<\/strong><\/span><\/h2>\n<p data-start=\"63\" data-end=\"373\" data-is-last-node=\"\" data-is-only-node=\"\">This study demonstrates how NLRP1 inflammasome screening, more specifically how automated high-content imaging and Sygnature\u2019s integrated screening workflow can be effectively applied to innate immunity targets, enabling early-stage identification and validation of promising NLRP1 pathway modulators in drug discovery.<\/p>\n<p><strong>Download the poster to explore how Sygnature Discovery\u2019s high-throughput screening platform is used for NLRP1 inflammasome formation.<\/strong><\/p>\n<p><span style=\"font-size: 12pt;\">Sygnature Discovery supports complex <a href=\"https:\/\/www.sygnaturediscovery.com\/drug-discovery\/bioscience\/ion-channel-screening\/\" target=\"_blank\" rel=\"noopener\">cell-based screening<\/a> with high-content imaging, assay development, compound profiling, and target validation to drive drug discovery forward with the best chance at a successful <a href=\"https:\/\/www.sygnaturediscovery.com\/drug-discovery\/integrated-drug-discovery\/hit-identification\/\" target=\"_blank\" rel=\"noopener\">hit finding<\/a> and validation stage.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":2902,"template":"","category":[706,681,708,752],"class_list":["post-4156","poster","type-poster","status-publish","has-post-thumbnail","hentry","category-assay-development","category-bioscience","category-high-throughput-screening","category-ii"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>High-Content NLRP1 Inflammasome Screening<\/title>\n<meta name=\"description\" content=\"Discovery how Sygnature Discovery&#039;s high-content screening platform identified novel modulators of NLRP1 inflammasome formation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"High-Content NLRP1 Inflammasome Screening\" \/>\n<meta property=\"og:description\" content=\"Discovery how Sygnature Discovery&#039;s high-content screening platform identified novel modulators of NLRP1 inflammasome formation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T14:04:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/1747061356865-50f051c4-89a3-4636-8096-db940d353536_1-e1747061402218.png\" \/>\n\t<meta property=\"og:image:width\" content=\"437\" \/>\n\t<meta property=\"og:image:height\" content=\"618\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/high-content-screen-nlrp1-inflammasome-modulators\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/high-content-screen-nlrp1-inflammasome-modulators\\\/\",\"name\":\"High-Content NLRP1 Inflammasome Screening\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/high-content-screen-nlrp1-inflammasome-modulators\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/high-content-screen-nlrp1-inflammasome-modulators\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1747061356865-50f051c4-89a3-4636-8096-db940d353536_1-e1747061402218.png\",\"datePublished\":\"2025-05-21T07:00:34+00:00\",\"dateModified\":\"2026-01-22T14:04:29+00:00\",\"description\":\"Discovery how Sygnature Discovery's high-content screening platform identified novel modulators of NLRP1 inflammasome formation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/high-content-screen-nlrp1-inflammasome-modulators\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/high-content-screen-nlrp1-inflammasome-modulators\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/high-content-screen-nlrp1-inflammasome-modulators\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1747061356865-50f051c4-89a3-4636-8096-db940d353536_1-e1747061402218.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1747061356865-50f051c4-89a3-4636-8096-db940d353536_1-e1747061402218.png\",\"width\":437,\"height\":618,\"caption\":\"Sygnature's SLAS Poster discussing NLRP1 screening through HTS\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/high-content-screen-nlrp1-inflammasome-modulators\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A &#8216;Speckulative&#8217; Screen: High-Content MTS Against NLRP1 Mediated Inflammasome Formation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"High-Content NLRP1 Inflammasome Screening","description":"Discovery how Sygnature Discovery's high-content screening platform identified novel modulators of NLRP1 inflammasome formation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/","og_locale":"fr_CA","og_type":"article","og_title":"High-Content NLRP1 Inflammasome Screening","og_description":"Discovery how Sygnature Discovery's high-content screening platform identified novel modulators of NLRP1 inflammasome formation.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/","og_site_name":"Sygnature","article_modified_time":"2026-01-22T14:04:29+00:00","og_image":[{"width":437,"height":618,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/1747061356865-50f051c4-89a3-4636-8096-db940d353536_1-e1747061402218.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/","name":"High-Content NLRP1 Inflammasome Screening","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/1747061356865-50f051c4-89a3-4636-8096-db940d353536_1-e1747061402218.png","datePublished":"2025-05-21T07:00:34+00:00","dateModified":"2026-01-22T14:04:29+00:00","description":"Discovery how Sygnature Discovery's high-content screening platform identified novel modulators of NLRP1 inflammasome formation.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/1747061356865-50f051c4-89a3-4636-8096-db940d353536_1-e1747061402218.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/1747061356865-50f051c4-89a3-4636-8096-db940d353536_1-e1747061402218.png","width":437,"height":618,"caption":"Sygnature's SLAS Poster discussing NLRP1 screening through HTS"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/high-content-screen-nlrp1-inflammasome-modulators\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"A &#8216;Speckulative&#8217; Screen: High-Content MTS Against NLRP1 Mediated Inflammasome Formation"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/4156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/poster"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/4156\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/2902"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=4156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=4156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}